PayPay Corp. (Ticker: PAYP US) is a Japanese company specializing in digital payments and financial services. As a leading fintech provider in Japan, the company operates a comprehensive ecosystem connecting tens of millions of users and merchants through its all-in-one mobile platform. PayPay Corp. began trading on the NASDAQ on March 12, 2026, offering 55 million American Depositary Shares (ADS) priced at $16.00 per share, which was below its initially marketed range. The IPO raised approximately $880 million, giving the company a valuation of $10.7 billion.

The company functions as an integrated digital finance portal, having expanded its original code-based payment solution through PayPay Card Corporation, PayPay Bank Corporation, and PayPay Securities Corporation. According to the prospectus, PayPay Corp. intends to use the IPO proceeds to further its goal of becoming a digital finance platform for all, supporting its scalable network across payments, banking, and investment services. The offering is led by a substantial syndicate of underwriters, including Goldman Sachs, J.P. Morgan, Mizuho, and Morgan Stanley, among others.

Saleh Abdulaziz Al Rashed & Sons Co (Ticker: SALEHALR AB) is a Saudi Arabian company specializing in the mining and construction materials sector. Saleh Abdulaziz Al Rashed & Sons is expected to list on the Saudi Arabia exchange on March 11, 2026, offering 5.58 million shares at a price of SAR 45.00 per share. The IPO is expected to raise an offer size of SAR 251.10 million (approximately USD 66.97 million).

Founded in 1975, the company operates across mining, drilling, assembling, logistics, and trading. It supplies essential building products, including cement, aggregates, and crusher components, to major national initiatives like NEOM and the Red Sea projects.

According to sources, the offering consists of 100% secondary shares, indicating that the IPO proceeds will be directed entirely to the selling shareholders rather than the company itself. Reportedly, the managers and advisers for the offering include ANB Capital Co, Al Rajhi Capital, Alinma Capital, Alistithmar for Financial Securities & Brokerage, Bank Al-Jazira, and Derayah Financial LLC.

MeiG Smart Technology Co Ltd (Ticker: 3268 HK) is a Chinese company focusing on wireless communication modules and solutions, specifically high-computing-power smart modules for the Internet of Things (IoT), intelligent connected vehicles, and wireless broadband sectors. MeiG Smart Technology plans to list its H shares on the Hong Kong Stock Exchange on March 10, 2026, planning to offer 35,000,000 shares at an expected price of HKD 28.86, raising a total offer size of HKD 1.01 billion (approximately USD 129.11 million).

According to sources, MeiG Smart Technology plans to use the IPO proceeds for research and development, enhancing product capacity, brand promotion, business development, working capital, strategic acquisitions, and debt repayment. Reportedly, the company ranked fourth in the global wireless communication module industry by revenue in 2024, holding a 6.4% market share. Its customized offerings address complex integration challenges, providing combined hardware, software, and tailored R&D services to its clients. China International Capital Corporation Hong Kong Securities Limited is acting as the sponsor for the offering, supported by a syndicate including BNP Paribas Securities.

Gabler Group AG (Ticker: XK4 GR) is a German company specializing in mission-critical subsea technologies, including submarine systems, communications, and power. Gabler Group plans to list on the Frankfurt Stock Exchange (Scale segment) on March 9, 2026, planning to offer up to 3,018,750 shares at €37.00 to €47.00 per share, raising €112 million to €142 million (approximately $132.2 million to $167.6 million). The company has an implied valuation of $264.1 million to $335.4 million. Gabler Group reportedly plans to use the IPO proceeds to fund balance sheet strengthening, R&D, growth, and acquisitions.

The offering consists of 1.05 million newly issued shares alongside 1.575 million existing shares sold by current backer Possehl Group, which plans to retain a minority holding. The deal includes a 15% greenshoe option, leading to a 49.9% free float if fully exercised, and features a 12-month lock-up period. According to sources, order books were fully covered on the first day of the offering. Cantor Fitzgerald acts as the sole global coordinator and joint bookrunner, alongside Bankhaus Metzler as joint bookrunner.

Estun Automation Co Ltd (Ticker: 2715 HK) is a Chinese company focusing on industrial robotics, intelligent manufacturing systems, core automation components, and motion control systems. Estun Automation plans to list on the Hong Kong Stock Exchange on March 9, 2026, planning to offer 96,780,000 shares at a price range of HKD 15.36 to HKD 17.00, raising up to HKD 1.65 billion (approximately USD 210.30 million). Based on this pricing, the expected market capitalization at offer is approximately USD 1.90 billion to USD 2.10 billion.

According to sources, Estun Automation plans to use the IPO proceeds for research and development, enhancing product capacity, brand promotion, business development, working capital, strategic acquisitions, and debt repayment. Reportedly, the company ranked first among domestic manufacturers in China's industrial robotic solutions market by shipment volume for years and surpassed foreign brands within the domestic market in the first half of 2025. Additionally, the firm ranked sixth globally by revenue in 2024. Huatai Financial Holdings (Hong Kong) Limited is acting as the sole sponsor for the offering, supported by a syndicate of global coordinators.

Shenzhen Zhaowei Machinery & Electronic Co Ltd (Ticker: 2692 HK) is a Chinese company focusing on integrated micro transmission and drive system products. Shenzhen Zhaowei plans to list its H shares on the Hong Kong Stock Exchange on March 9, 2026, planning to offer 26,748,300 shares, raising HKD 1.97 billion (approximately USD 251.91 million).

According to sources, Shenzhen Zhaowei plans to use the IPO proceeds for research and development, enhancing product capacity, brand promotion, business development, working capital, and strategic acquisitions. Reportedly, the company ranked as the number one provider of integrated micro transmission and drive systems in China and fourth globally by 2024 revenue, holding 405 relevant patents. The company integrates transmission systems, micro motor systems, and electronic control systems for applications across intelligent automotive, consumer technology, healthcare, and robotics sectors. According to filings, Deutsche Securities Asia Limited and China Merchants Securities (HK) Company Limited are acting as joint sponsors for the offering, supported by a syndicate of global coordinators and bookrunners.

ALSCO Pooling (Ticker: 2649 HK) is a Chinese company focusing on shared-use logistics and reusable packaging, primarily serving automotive parts manufacturers. ALSCO manages a network where clients rent durable pallets and crates, with ALSCO handling the storage, cleaning, and distribution.

ALSCO plans to list its H shares on the HKEX on March 9, 2026, planning to offer 20,336,000 shares at a price range of HKD 11.00 to HKD 14.00, raising between HKD 223.70 million and HKD 284.70 million (approximately USD 28.68 million to USD 36.50 million). Based on this pricing, the expected market capitalization at offer is approximately USD 127.40 million to USD 162.14 million.

ALSCO Pooling plans to use the IPO proceeds for research and development, enhancing product capacity, brand promotion, business development, working capital, and strategic acquisitions. The company ranked as the largest provider in the Chinese automotive shared packaging market by 2024 revenue, managing an asset base of approximately 1.5 million reusable containers across 78 warehouses. China Securities (International) Corporate Finance Company Limited is the sponsor for the offering.

MiniMed Group, Inc. (Ticker: MMED US) is an American company specializing in diabetes care technology, including automated insulin pumps, continuous glucose monitors, and smart insulin pens. MiniMed plans to list on the NASDAQ on March 5, 2026, offering 28 million shares at a price range of $25.00 to $28.00 per share. The IPO is expected to raise up to $784 million, giving the company an estimated market capitalization of up to $7.86 billion. The company is going public as a spin-off from its parent company, Medtronic.

Post-IPO, Medtronic will reportedly retain a 90% stake before planning a complete split-off to shareholders 180 days later. According to sources, MiniMed plans to use the IPO proceeds to repay intercompany debt and purchase assets, while retaining $350 million in cash. The company reportedly operates in approximately 80 countries with a workforce of 8,000 employees, serving over 640,000 users. For the trailing twelve months ending in October 2024, the business reportedly generated $2.89 billion in revenue.

K Bank Co. Ltd. (Ticker: 279570 KS) is a South Korea-based financial institution operating as the country's first internet-only bank. Headquartered in Seoul, the company provides fully digital banking services, including deposits, credit loans, mortgage lending, and payment services, without operating physical branches. The company plans to list on the KOSPI market on March 5, 2026.

The IPO involves the offering of 60 million shares at a price range of KRW 8,300 to KRW 9,500 per share. At the top of this range, the total offer size is expected to be KRW 570 billion (approximately US$386 million). The structure of the offering is reportedly split evenly, with 50% comprising newly issued primary shares and 50% consisting of secondary shares sold by existing shareholders. Major shareholders include BC Card, which holds a 33.72% stake, and Woori Bank. The offering is being managed by NH Investment & Securities, Samsung Securities, and Shinhan Investment & Securities.

Geekly, Inc. (Ticker: 505A JP) is a Japanese company specializing in recruitment and human resource services specifically tailored for the IT, Web, and game industries. The company plans to list on the Tokyo Stock Exchange Standard Market on February 27, 2026. The IPO comprises a 100% secondary offering of 3,210,000 existing shares, meaning the company will not issue new shares. Consequently, the company will not receive proceeds from the offering; instead, funds will reportedly go to selling shareholders, including the representative director Takahiro Okuyama and Bridge Investment Co., Ltd.

With a tentative price range of JPY 1,880 to JPY 1,900 per share, the offer size is expected to be approximately JPY 6.1 billion (reportedly USD 38.53 million). Nomura Securities Co., Ltd. is acting as the lead underwriter. Founded in 2011 and headquartered in Shibuya, Tokyo, Geekly provides matching services for engineers, creators, and game industry professionals. For the fiscal year ended May 2025, the company reported non-consolidated revenue of over JPY 7.1 billion.

Generate Biomedicines (Ticker: GENB US) is an American clinical-stage generative biology company specializing in artificial intelligence for biotechnology and drug design. Generate Biomedicines plans to list on the NASDAQ on February 27, 2026, planning to offer 25.0 million shares at a price range of $15.00 to $17.00, raising an estimated $400 million. The company is projected to have a market capitalization of approximately $2 billion

The company operates a proprietary platform integrating computational innovation with scalable biohardware to engineer novel therapeutics. According to sources, the company has progressed three computationally engineered proteins into human testing, including GB-0895, an investigational monoclonal antibody currently in Phase 3 clinical trials for severe asthma. Additional candidates targeting oncology are reportedly expected to advance into Phase 1 trials in 2026. The company is domiciled in the United States, originally founded in 2018. The IPO will reportedly be managed by joint bookrunners including Goldman Sachs, Morgan Stanley, Piper Sandler, Guggenheim Securities, and Cantor.

Innovacell Inc. (Ticker: 504A JP) is a Japan-based biotechnology company developing regenerative medicine products specifically targeted at treating fecal and urinary incontinence. Headquartered in Tokyo, the company operates with a key subsidiary, Innovacell GmbH, located in Innsbruck, Austria. The company plans to list on the Tokyo Stock Exchange Growth Market on February 24, 2026.

Innovacell intends to offer a total of approximately 9.13 million shares, split between 8.4 million new shares and roughly 725,000 existing shares. The indicative price range is set between JPY 1,290 and JPY 1,350 per share. At the top of this range, the IPO is expected to raise JPY 12.32 billion (approximately US$78 million), giving the company a reported market capitalization of roughly US$280 million. The offering is led by Nomura Securities as the lead underwriter, with SBI Securities also participating. The company was established in 2021 and is currently led by Representative Director Jason Seger. Recent financial data indicates the company is in a pre-profit growth stage, having recorded net losses in the fiscal year ending December 2024 as it continues its research and development efforts.

Haizhi Tech Group (Ticker: 2706 HK) is a China-based artificial intelligence company specializing in data intelligence and knowledge graph technology. The company plans to list on the Hong Kong Stock Exchange on February 13, 2026, offering 28.03 million shares at a price range of HKD 25.60 to HKD 28.00 per share. Through this offering, Haizhi Tech Group aims to raise approximately HKD 784.9 million (approx. US$100.4 million). At this pricing, the company commands a market capitalization between HKD 10.3 billion and HKD 11.2 billion.

The company’s core business revolves review around its proprietary "Atlas" software suite. This technology uses "knowledge graphs", which map complex relationships between different data points, to help enterprises manage information more effectively than traditional databases. Haizhi Tech claims to integrate these structured graphs with Large Language Models (LLMs) to reduce AI errors, known as "hallucinations." According to its prospectus, IPO proceeds will fund research and development, brand promotion, and potential strategic acquisitions. The offering is sponsored by CMB International, Shenwan Hongyuan, and BOCI Asia.

Shenzhen Woer Heat-Shrinkable Material Co., Ltd. (Ticker: 9981 HK) is a China-based manufacturer specializing in electrical power transmission solutions, specifically heat shrink tubing, wiring and connectors. The company plans to list on the Hong Kong Stock Exchange on February 13, 2026. It intends to offer approximately 140 million H-shares at a fixed price of HKD 20.09 per share, aiming to raise HKD 2.81 billion (approximately US$359.9 million).

According to its prospectus, Shenzhen Woer is the global leader in the heat-shrinkable materials industry with a reported 20.6% market share and ranks fifth globally in telecoms cables. Its diverse product portfolio includes high-speed copper cables, new energy vehicle (NEV) charging guns, and power battery safety protection systems. For the fiscal year 2024, the company reported revenue of RMB 6.92 billion. The company plans to utilize the IPO proceeds to enhance research and development, expand production capacity, and support brand promotion and strategic acquisitions. The offering is jointly sponsored by China Merchants Securities (HK) and China Securities (International).

ARKO Petroleum Corp. (Ticker: APC US) is a United States-based fuel distribution company specializing in wholesale fuel supply and fleet fueling services. Headquartered in Richmond, Virginia, the company plans to list on the NASDAQ on February 12, 2026. ARKO Petroleum intends to offer 10.5 million shares at a price range of $18.00 to $20.00, targeting a raise of approximately $199.5 million. At the midpoint of this range, the company reportedly commands a market capitalization of $864.5 million.

Formed by ARKO Corp. (Nasdaq: ARKO), a major U.S. convenience store operator, ARKO Petroleum functions as a distinct entity supplying fuel to its parent company's retail sites, as well as to third-party dealers and commercial fleets across more than 30 states. The company operates through three segments: Wholesale, Fleet Fueling, and GPMP, distributing over 2.1 billion gallons of fuel annually. According to its filings, a key business objective for the new entity is to generate and increase quarterly cash distributions to stockholders. The IPO is being managed by a syndicate including UBS Investment Bank, Raymond James, Stifel, Mizuho, and Capital One Securities.

Wuxi Lead Intelligent Equipment Co., Ltd. (Ticker: 470 HK) is a China-based company specializing in intelligent manufacturing solutions for the new energy industry. Headquartered in Wuxi, the company is reportedly the world’s largest provider of lithium-ion battery intelligent equipment by revenue, while also supplying machinery for photovoltaic, hydrogen fuel cell, and automotive production. Wuxi Lead plans to list on the Hong Kong Stock Exchange on February 11, 2026, offering approximately 93.62 million H-shares at a price of HKD 45.80 per share.

The offering is expected to raise HKD 4.29 billion (approximately US$548.9 million). At this pricing, the company reportedly commands a market capitalization of HKD 106.8 billion (approximately US$13.7 billion). According to its prospectus, Wuxi Lead plans to use the IPO proceeds to fund research and development, expand production capacity, and finance potential strategic acquisitions. The offering is being sponsored by CITIC Securities and J.P. Morgan, with a syndicate of underwriters that includes CLSA, BOCI Asia, and Huatai Financial.

SOLV Energy, Inc. (Ticker: MWH US) is a United States-based company specializing in infrastructure services for the power industry, particularly utility-scale solar and battery storage projects. SOLV Energy plans to list on the NASDAQ on February 11, 2026, offering 20.5 million shares of Class A common stock at a pricing range of $22.00 to $25.00. The IPO is expected to raise approximately $512.5 million, with the company commanding a valuation of approximately $5 billion at the top end of the range.

The company reportedly plans to use the IPO proceeds primarily to repay roughly $402 million in term loans, with the remaining funds allocated toward general corporate purposes, including growth initiatives and potential acquisitions. Founded in 2008 as Swinerton Renewable Energy, the business originally operated as a division of Swinerton Builders before being acquired and rebranded by private equity firm American Securities in 2021. American Securities is expected to remain a majority shareholder following the offering. Jefferies and J.P. Morgan are serving as the lead book-running managers for the transaction, which consists entirely of primary shares.

AGI Inc. (Ticker: AGBK US) is a Brazil-focused financial technology company incorporated in the Cayman Islands, specializing in secured lending and banking services for underserved populations. The company focuses on providing credit to social security beneficiaries and public sector workers, utilizing a hybrid engagement model that combines a digital platform with over 1,100 physical "Smart Hubs" across Brazil. AGI Inc. plans to list on the NYSE on February 11, 2026, offering a downsized 20.0 million Class A common shares at an amended price range of $12.00 to $13.00 per share.

The IPO is expected to raise $260 million USD. According to regulatory filings, AGI Inc. plans to use the net proceeds for general corporate purposes, which may include future acquisitions or investments in new technologies. The offering is managed by a syndicate including Banco Bradesco BBI, Banco BTG Pactual, Itau BBA USA Securities, SG Americas Securities, Santander US Capital Markets, and XP Investimentos. The company reportedly serves nearly 6.4 million active clients and operates under a dual-class structure, ensuring the controlling shareholder retains majority voting power post-listing.

Ridge Outdoor (Ticker: 2720 HK) is a China-based company specializing in the manufacturing of fishing-related equipment. As the world's largest manufacturer in this niche with a reported 23.1% global market share in 2024, the company produces items such as fishing chairs, bedchairs, backpacks, and tents. Ridge Outdoor operates a dual business model, primarily deriving revenue from OEM/ODM services for global retailers and brands like Decathlon, Fox, and Nash, while also expanding its Own Brand Management (OBM) segment, which includes the UK-based carp fishing brand, Solar.

Ridge Outdoor plans to list on the Hong Kong Stock Exchange on February 10, 2026. The company plans to offer 28.2 million shares at a price range of HKD 11.25 to HKD 12.25. The IPO aims to raise up to HKD 345.5 million (approximately USD 44.4 million). At the proposed pricing, the company anticipates a market capitalization ranging from HKD 1.44 billion to HKD 1.57 billion (approximately USD 193 million at the midpoint). Reportedly, the company plans to use the proceeds to fund R&D and production capacity expansion, brand promotion, and strategic acquisitions. The offering is sponsored by China International Capital Corporation (CICC).

Axera (Ticker: 600 HK) is a China-based fabless semiconductor company specializing in artificial intelligence inference systems-on-a-chip (SoCs). The company delivers high-performance perception and computing platforms for edge and endpoint applications, featuring its proprietary "Axera Neutron" mixed-precision neural processing unit (NPU) and "Axera Proton" AI-ISP. According to filing documents, Axera ranked as the largest global provider of mid-to-high-end visual on-device AI inference chips by shipments in 2024.

Axera plans to list on the Hong Kong Stock Exchange on February 10, 2026. The company is offering approximately 104.9 million shares at a price of HKD 28.20 per share, aiming to raise approximately HKD 2.96 billion (roughly USD 379 million). Axera reportedly plans to use the IPO proceeds for research and development, expanding product capacity, brand promotion, business development, and strategic acquisitions. The offering is sponsored by CICC, BOCOM International, and Guotai Junan Capital. While the company has reported net losses in recent years, it recorded a revenue CAGR of 206.8% from 2022 to 2024, driven by growth in smart vehicle and edge computing sectors.

Montage Technology Co Ltd (Ticker: 6809 HK) is a China-based fabless integrated circuit design company specializing in interconnect solutions for cloud computing and artificial intelligence infrastructure. The company focuses on developing high-performance memory interface chips, including solutions for DDR2 through DDR5 standards, as well as PCIe and CXL interconnect chips designed to address data transmission bottlenecks in data centers. According to industry reports, Montage Technology ranked as the largest memory interconnect chip supplier globally by revenue in 2024, holding a 36.8% market share.

Montage Technology plans to list on the Hong Kong Stock Exchange on February 9, 2026. The company is offering 65.89 million H-shares at an expected price of HKD 106.89 per share. The IPO aims to raise approximately HKD 7.04 billion, which is equivalent to roughly USD 902 million. According to filing documents, the company plans to use the proceeds for research and development, expanding product capacity, brand promotion, business development, and potential strategic acquisitions. The offering is jointly sponsored by CICC, Morgan Stanley, and UBS, with Goldman Sachs and CLSA also acting as underwriters.

Muyuan Foods Co Ltd (Ticker: 2714 HK) is a China-based company specializing in the industrial-scale production of pork and smart hog farming. Operating a vertically integrated business model, the company covers the entire value chain from feed production and breeding to slaughtering and meat processing. Reportedly ranked first globally in hog farming production capacity and sales volume, Muyuan utilizes proprietary technology to manage biosecurity and environmental efficiency across its operations.

Muyuan Foods plans to list on the Hong Kong Stock Exchange on February 6, 2026. The company is planning to offer 273.95 million shares at HKD 39.00 per share, raising approximately HKD 10.68 billion (approx. USD 1.37 billion). According to filing documents, Muyuan Foods plans to use the IPO proceeds for R&D, expanding product capacity, brand promotion, and general working capital. The offering is structured as an issuance of H-shares and is sponsored by Morgan Stanley, Goldman Sachs, and CITIC Securities. This listing represents a significant expansion for the company, which has reportedly maintained the highest revenue growth among top global pork producers over the last decade.

AgomAb Therapeutics (Ticker: AGMB US) is a Belgium-based clinical-stage biotechnology company specializing in the development of fibrosis treatments for immunology and inflammatory diseases. The company plans to list on the NASDAQ on February 6, 2026. AgomAb intends to offer 12.5 million American Depositary Shares (ADS) at a price range of $15.00 to $17.00 per share. At the midpoint of this range, the IPO would raise $200 million, resulting in a market capitalization of approximately $779.8 million.

The company’s mission focuses on resolving fibrosis and restoring organ function by targeting specific signaling pathways, such as the TGFβ pathway. Its lead product candidate, Ontunisertib (AGMB-129), is an oral treatment being developed for Crohn’s disease with fibrostenosis. Additionally, AgomAb is developing AGMB-447, an inhaled treatment for idiopathic pulmonary fibrosis (IPF). Reportedly, the company plans to use the IPO proceeds to fund the continued clinical development of these candidates. AgomAb has not generated product revenue to date and reported a net loss of €46.4 million for the year ended December 31, 2024. The offering is led by underwriters J.P. Morgan, Morgan Stanley, Leerink Partners, and Van Lanschot Kempen.

Distinct Healthcare Co Ltd (Ticker: 2677 HK) is a China-based private medical service provider specializing in the mid-to-high-end healthcare market. The company plans to list on the Main Board of the Hong Kong Stock Exchange (HKEX) on February 6, 2026. Distinct Healthcare intends to offer 4.75 million shares at a price range of HKD 57.70 to HKD 66.60 per share. If priced at the top of the range, the IPO is expected to raise up to HKD 316.35 million (approximately 40.5 million USD). At the proposed pricing, the company anticipates a market capitalization ranging from HKD 3.71 billion to HKD 4.29 billion (roughly 476 million to 549 million USD).

Operating a network of 19 institutions across major Chinese cities, including clinics and hospitals, and additional clinics in Singapore and Malaysia, Distinct Healthcare reportedly focuses on a "whole-family care" model integrating in-person and tele-healthcare services for the mass affluent population. Notable shareholders include Tencent Holdings and Tian Tu Capital. According to listing documents, the company plans to use the IPO proceeds for research and development, expanding product capacity, strategic acquisitions, and general working capital. SPDB International Capital and Haitong International Capital are acting as joint sponsors for the offering.

Once Upon a Farm, PBC (Ticker: OFRM US) is an American company specializing in the manufacturing, distribution, and marketing of fresh, organic, and nutrient-packed food products for babies and children. The company plans to list on the NYSE on February 6, 2026. The IPO involves an offering of 10,997,209 shares within a price range of $17.00 to $19.00, aiming to raise approximately $198 million USD (at the midpoint).

The deal structure comprises 7,631,537 primary shares and 3,365,672 secondary shares, indicating that proceeds will reportedly be split between the firm and existing selling shareholders. Organized as a Public Benefit Corporation, the company focuses on "farm fresh first" nutrition, offering cold-pressed pouches, frozen meals, and snacks free from added sugar and preservatives. Co-founded by John Foraker and actress Jennifer Garner, the brand utilizes an omnichannel strategy, selling through direct-to-consumer platforms and over 20,000 retail locations, including Target and Whole Foods. J.P. Morgan and Goldman Sachs are serving as joint lead bookrunners for the transaction.

SpyGlass Pharma, Inc. (Ticker: SGP US) is a United States-based late-stage biopharmaceutical company specializing in sustained drug delivery solutions for chronic eye conditions. Headquartered in Aliso Viejo, California, the firm focuses on transforming the treatment paradigm for open-angle glaucoma and ocular hypertension. Its lead product candidate, the BIM-IOL System, consists of proprietary drug pads attached to an intraocular lens, designed for implantation during routine cataract surgery to deliver bimatoprost over three years. The company plans to list on the Nasdaq Global Select Market on February 6, 2026.

SpyGlass Pharma intends to offer 9.375 million shares at a price range of USD 15.00 to USD 17.00, seeking to raise USD 150 million. At the midpoint of this range, the company commands a fully diluted market capitalization of approximately USD 549 million. According to regulatory filings, the IPO proceeds will primarily fund the advancement of its platform through two registrational Phase 3 clinical trials initiated in July 2025. The offering is managed by Jefferies, Leerink Partners, Citigroup, and Stifel. The company is led by CEO Patrick Mooney and backed by investors including New Enterprise Associates and RA Capital.

Shenzhen Han's CNC Technology Co Ltd (Ticker: 3200 HK) is a China-based company specializing in the research, development, and manufacturing of specialized equipment for the printed circuit board (PCB) industry. Reportedly ranked as the largest specialized PCB equipment manufacturer in China by revenue in 2024, the company provides solutions for critical production processes, including drilling, photolithography, lamination, and testing. Han's CNC previously listed on the Shenzhen Stock Exchange’s ChiNext Market in 2022 and serves diverse downstream sectors such as consumer electronics, automotive, and data storage.

Han's CNC plans to list on the Hong Kong Stock Exchange on February 6, 2026. The company is offering approximately 50.45 million H-shares at a price of HKD 95.80 per share, aiming to raise HKD 4.83 billion (approximately USD 619 million). According to the filing, the company plans to use the IPO proceeds to enhance its research and development capabilities, expand production capacity, and fund general working capital and strategic acquisitions. The offering is sponsored by China International Capital Corporation and includes a greenshoe facility of approximately 7.57 million shares.

Forgent Power Solutions, Inc. (Ticker: FPS US) is a United States-based company specializing in the design and manufacture of electrical distribution equipment for data centers, the power grid, and energy-intensive industrial facilities. The company focuses on engineered-to-order custom products to support demand in cloud computing, AI, and electrification. Forgent Power Solutions plans to list on the New York Stock Exchange on February 5, 2026, planning to offer 56,000,000 shares at a price range of $25.00 to $29.00 per share. The offering is expected to raise approximately $1.51 billion at the midpoint, with a maximum size of roughly $1.62 billion in USD.

According to the prospectus, Forgent Power Solutions plans to use the net proceeds from the IPO to redeem interests in an operating subsidiary held by existing equity owners controlled by Neos Partners, LP. Consequently, the company reportedly will not retain capital for general corporate operations from this transaction. The offering includes both primary shares and secondary shares sold by parent entities. Lead underwriters for the transaction include Goldman Sachs, Jefferies, and Morgan Stanley. The company reported revenue growth of 56% for the fiscal year 2025.

Bob’s Discount Furniture, Inc. (Ticker: BOBS US) is a U.S.-domiciled, national omnichannel retailer of value home furnishings. The company operates a network of 206 showrooms across 26 states, offering a curated "Good, Better, Best" product assortment anchored by an "Everyday Low Prices" strategy. Bob’s Discount Furniture plans to list on the NYSE on Thursday, February 5, 2026. The company intends to offer 19,450,000 primary shares within a price range of $17.00 to $19.00 per share.

At the midpoint of the range, the IPO aims to raise approximately $350 million USD. The offering is led by J.P. Morgan and Morgan Stanley. Upon completion, the company will remain a "controlled company" majority-owned by Bain Capital. According to the filings, Bob’s Discount Furniture plans to use the net proceeds to prepay outstanding indebtedness under its Term Loan Facility, funds which were reportedly utilized to pay a cash dividend to stockholders in October 2025, and for general corporate purposes.

Eikon Therapeutics, Inc. (Ticker: EIKN US) is a U.S. biopharmaceutical company specializing in the development of innovative medicines for serious unmet medical needs, with an initial focus on oncology. The company plans to list on the NASDAQ on February 5, 2026, offering 17,648,000 shares at a price range between $16.00 and $18.00. At the midpoint of this range, the IPO is expected to raise approximately $300 million. Eikon Therapeutics targets a valuation of up to $908.2 million.

According to the company, the proceeds from the IPO are intended to advance its clinical pipeline, which includes the mid-to-late stage drug candidate EIK1001. The company utilizes a high-throughput drug discovery platform based on the work of Nobel Prize-winning co-founder Eric Betzig and is led by Dr. Roger M. Perlmutter, a former research chief at Merck. The offering is managed by a bookrunning group including J.P. Morgan, Morgan Stanley, BofA Securities, and Cantor. Since its founding in 2019, the company has reportedly raised over $1 billion from private investors such as Lux Capital and Foresite Capital.